VIM and renal cell carcinoma: In agreement with the data observed on E-cadherin expression (Figure 6C), only the IL-2Rγ/JAK3 co-transfection in RCC inhibits the cytokeratins down-regulation and vimentin upregulation observed after 48 hours of rhIL-15 treatment.